-
Specially prepared maggots have been approved by the FDA since 2004 for neuropathic foot ulcers, pressure ulcers,venous stasis ulcers, and traumatic and post-surgical wounds. Insurance companies spend thousands of dollars for an amputation but back off at a $100.00 maggot treatment. The American...
-
Personalized Medicine will create many answers and solutions in healthcare, but will we have the money to afford it? I post quite a bit about genomics and personalized medicine on the blog here and the one thing it has in common with the rest of healthcare is cost. The success of personalized...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-14-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, Other Items of Interest, personalized medicine, healthcare, Medical Records, FDA, integration, CMS, Leavitt
-
Sure Scripts has a wealth of information available and I have summarized a portion of some of the important facts here. You can also use .png?imgmax=800" width="197" height="126" alt="" /> the interactive map found here to see which pharmacies participate in your zip code or state area. Most...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-02-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, EMR, healthcare, Medical Records, EHR, PHR, e-prescribing, FDA, Pharmacies, DEA, Sure Scripts, federal disasters, Emergency medicine, ICER.org
-
FDA approved - investigational? Why do we have issues with insurance companies? Where does the money get spent, California is trying to change this to where 85% of premium money goes towards healthcare. It does make you wonder sometimes when you see so many projects funded by insurance...
-
More marketing and potential hidden information seems to be making it's way to front, and interesting now on who wants to be reimbursed, insurance companies among the group. This appears to be an all out battle ground here. Weight gain and diabetes as side effects? Class action...
-
Cerner president speaks out about the insurance business, "they need to be redefined". Amgen CEO and President Kevin Sharer called for a better structured FDA . Overall the summary statement says the same thing I have brought up time and time again, who's going to to...
-
As the old saying goes, things roll downhill and Siemens was the straw that broke the camel's back here. Recently Siemens has been in the news with their own issues with restructuring and lay offs. There are other creditors including Clinical Laboratories of Hawaii, Ewa Beach, $3.9 million;...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-30-2008
Filed under:
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, healthcare, Physicians, FDA, Hospitals, Nursing, bankruptcy, Economics, Desperate Hosptials, Venture Capitalists, Transparancy, Layoffs, Debt consolidation, Overseas Investments, Vendors
-
More additional affiliations for the FDA to gather information. In the news recently have been other agreements with companies such as Blue Cross and others who will be providing data to also study the effects of drugs through medical record information in their files, based on claims, etc. No...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-18-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, health insurance, healthcare IT, Pharma, Biotech, FDA, Medco, Pharmacogonomics
-
The most amazing part of this article is the cost compared to OxyContin, that was an eye opener for me, not being acquainted with pain killing medications. Xanax and Valium do not mix here either and we all remember the Anna Nicole Smith death, which probably accounted for bring methadone to the...
-
American Society of Clinical Oncology and Blue Cross/Blue Shield of Michigan will collect cancer information from 11 oncology practices in Michigan. Each physician will be paid around $3000.00 for their time in for the collection process. This is good for the exchange of information...
-
This is a big even in the move towards personalized medicine. This test will allow the physician to determine if the use of Herceptin is the right treatment for the patient with breast cancer! If it is determined not to work, then the patient is spared the expense and use of the drug, and...
-
Good news to help some of the financially strapped hospitals here in California, but how much will each one actually see, as 11.8 million among 480 hospitals is not a huge chunk of change. In the meantime though, the current woes for WellPoint continue over stiffer penalties. One report from last...
-
A couple weeks ago I had a couple posts referencing the partner ship with Anthem Blue Cross with utilizing their data bases for such a project as well...The new FDA white paper, titled "The Sentinel Initiative -- A National Strategy for Monitoring Medical Product Safety," ... totally amazing...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
05-22-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, My Commentaries, Genomics, healthcare, Health IT, Security, FDA, clinical trials, Medicare Part D, HL7, data bases